miralax
TRANSCRIPT
NURS 1566 Clinical Form 3: Clinical Medications Worksheets(You will need to make additional copies of these forms)
Generic Namepolyethylene glycol
Trade NameMiraLax
ClassificationTherapeutic: laxativesPharmacologic: osmotics
Dose17g in 8 oz liquid
RoutePO
Time/frequencyOnce/ Now
Peak2-4 days
OnsetUnknown
DurationUnknown
Normal dosage range17g. (One heaping teaspoon) in 8 oz. of water may be used for up to two weeks
Why is your patient getting this medicationConstipation
For IV meds, compatibility with IV drips and/or solutionsN/A
Mechanism of action and indications(Why med ordered)Acts as an osmotic agent, drawing water into the lumen of the GI tract. Indicated for evacuation of the GI tract without water or electrolyte imbalance.
Nursing Implications (what to focus on) Contraindications/warnings/interactions GI obstruction, Gastric retention, Toxic colitis, Megacolon/ Use cautiously in Abdominal pain of uncertain cause, particularly if accompanied by fever/ No significant interactions
Common side effectsabdominal bloating, cramping, flatulence, nausea,
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically)none
Lab value alterations caused by medicineNone found
Be sure to teach the patient the following about this medicationInform patient that 2-4 days may be required to produce a bowel movement. PEG should not be used for more than 2 wk. Prolonged, frequent, or excessive use may result in electrolyte imbalance and laxative dependence. Advise patient to notify health care professional if unusual cramps, bloating, or diarrhea occurs
Nursing Process- Assessment(Pre-administration assessment)Assess patient for abdominal distention, presence of bowel sounds, and usual pattern of bowel function
AssessmentWhy would you hold or not give this med?Diarrhea, obstruction
EvaluationCheck after givingA soft, formed bowel movement